$Vincera Pharma, Inc.(VINC)$ b

2024-10-08

$Vincera Pharma, Inc.(VINC)$ buy soon before the blast

Sorry, this post has been deleted

Share your positions with us! This is a column where you can find the winning trades of our fellow tigers. There probably are a few potential opportunities that you may have overlooked.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

Boybabyrage
2024-12-30
Boybabyrage
No bro, I don't have. Got potential?
- TigerGPTReplyKallu:
  As a professional financial analyst, let's analyze Vincera Pharma, Inc. (VINC) based on various dimensions:
  Business and Industry Analysis: Vincera Pharma operates in the pharmaceutical industry. Please note that I don't have access to specific details about the company's business and industry growth prospects. It is important to conduct thorough research on the company's products, pipeline, potential market size, competitive landscape, and regulatory environment to assess its long-term growth potential.
  
  Earnings Analysis: According to the earnings forecast, Vincera Pharma is expected to report negative earnings per share (EPS) in the coming years. For the fiscal year 2024, the forecasted EPS is -0.76 USD, while for the fiscal year 2025 and 2026, the forecasted EPS is -0.46 USD and -0.57 USD, respectively. These figures indicate a challenging financial outlook for the company.
  
  Analyst Recommendations and Target Price: There are 2 analysts covering Vincera Pharma. The consensus recommendation is 1 recommend, 1 buy. However, only 1 analyst provides a target price estimate. The mean target price is 6.0 USD, with a low estimate of 2.0 USD and a high estimate of 10.0 USD. Analyst recommendations and target prices should be carefully considered and evaluated in the context of individual investment goals and risk tolerance.
  
  Capital Flow: Over the past 5 days, Vincera Pharma has experienced mixed capital flow. On certain days, it witnessed an inflow of 880.02 to 30662.8 Yuan, while on others, it experienced outflows ranging from -64474.18 to -12540.06 Yuan. Capital flow data can provide insights into investor sentiment and market dynamics.
  
  Support and Resistance Price: As of December 27th, the support price for Vincera Pharma is 0.1854 USD, while the resistance price is 0.1954 USD. These levels represent potential price levels at which the stock may find support or face resistance in its upward movement.
  
  Profiteer Ratio: The profiteer ratio on December 27th was 0.4709, indicating a certain level of profit generated in the stock.
  
  It's important to note that the information provided above is based on available data and analysis up to December 27th. The stock market is subject to various risks, and investing in any stock involves inherent risks. Therefore, it is essential to conduct thorough research, consider different factors, and consult with a financial advisor before making any investment decisions.
  Please keep in mind that the information provided above is for reference purposes only and should not be considered as investment advice. The stock market is volatile, and prices can fluctuate. Make sure to assess your risk tolerance and investment objectives before making any investment decisions.
  Let me know if there's anything else I can assist you with!
- Kallu:
  Looks like.. But good for long term @Tiger_SG @TigerGPT
Kallu
2024-12-30
Kallu
@Boybabyrage bro do you have this $Vincera Pharma, Inc.(VINC)$

Leave a comment

{"i18n":{"language":"en_US"},"detailType":1,"isChannel":false,"data":{"magic":2,"id":357784684560448,"tweetId":"357784684560448","gmtCreate":1728359249847,"gmtModify":1728359254332,"author":{"id":4156648821928502,"idStr":"4156648821928502","authorId":4156648821928502,"authorIdStr":"4156648821928502","name":"Kallu","avatar":"https://community-static.tradeup.com/news/516672ce34e53607e5822f25111599cf","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":4,"crmLevelSwitch":0,"currentWearingBadge":{"badgeId":"44212b71d0be4ec88898348dbe882e03-1","templateUuid":"44212b71d0be4ec88898348dbe882e03","name":"Boss Tiger","description":"The transaction amount of the securities account reaches $100,000","bigImgUrl":"https://static.tigerbbs.com/c8dfc27c1ee0e25db1c93e9d0b641101","smallImgUrl":"https://static.tigerbbs.com/f43908c142f8a33c78f5bdf0e2897488","grayImgUrl":"https://static.tigerbbs.com/82165ff19cb8a786e8919f92acee5213","redirectLinkEnabled":0,"hasAllocated":1,"isWearing":1,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2024.03.02","exceedPercentage":"60.96%","individualDisplayEnabled":0},"individualDisplayBadges":[],"fanSize":22,"starInvestorFlag":false},"themes":[{"themeId":"7516f9ef7e8042739b8597466da26fe7","categoryId":"7cf744760f454845a1870a05ea4e151d","name":"Winning Trades","type":0,"rnLink":"https://laohu8.com/RN?name=RNTheme&page=/theme/detail&rndata={\"themeId\":7516f9ef7e8042739b8597466da26fe7}&rnconfig={\"headerBarHidden\": true}","description":"Share your positions with us! This is a column where you can find the winning trades of our fellow tigers. There probably are a few potential opportunities that you may have overlooked.","image":"https://community-static.tradeup.com/news/14c89d9656aedb9a4698e7996c575947"}],"images":[{"img":"https://community-static.tradeup.com/news/2cc8c7a2c9b9764c2e5e8ce88f4561a9"}],"coverImages":[{"img":"https://community-static.tradeup.com/news/2cc8c7a2c9b9764c2e5e8ce88f4561a9"}],"html":"<html><head></head><body><a href=\"https://ttm.financial/S/VINC\">$Vincera Pharma, Inc.(VINC)$</a> buy soon before the blast&nbsp; <t-t type=\"img\" src=\"https://community-static.tradeup.com/news/2cc8c7a2c9b9764c2e5e8ce88f4561a9\"></t-t></body></html>","htmlText":"<html><head></head><body><a href=\"https://ttm.financial/S/VINC\">$Vincera Pharma, Inc.(VINC)$</a> buy soon before the blast&nbsp; <t-t type=\"img\" src=\"https://community-static.tradeup.com/news/2cc8c7a2c9b9764c2e5e8ce88f4561a9\"></t-t></body></html>","text":"$Vincera Pharma, Inc.(VINC)$ buy soon before the blast","highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":4,"repostSize":0,"favoriteSize":0,"link":"https://ttm.financial/post/357784684560448","repostId":2473439200,"repostType":2,"isVote":1,"tweetType":1,"viewCount":296,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":["VINC"],"verified":2,"subType":0,"readableState":1,"langContent":"EN","currentLanguage":"EN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":["晒单贴"],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":47,"xxTargetLangEnum":"ORIG"},"commentList":[{"id":386993578680840,"commentId":"386993578680840","gmtCreate":1735521499108,"gmtModify":1735521504484,"authorId":4178332581629092,"author":{"id":4178332581629092,"idStr":"4178332581629092","authorId":4178332581629092,"name":"Boybabyrage","avatar":"https://community-static.tradeup.com/news/29a7c713cb016eb11214bce5eed37eed","vip":1,"currentWearingBadge":{"badgeId":"a83d7582f45846ffbccbce770ce65d84-1","templateUuid":"a83d7582f45846ffbccbce770ce65d84","name":"Real Trader","description":"Completed a transaction","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"hasAllocated":1,"isWearing":1,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2024.05.11","individualDisplayEnabled":0,"individualDisplaySort":0,"categoryType":1100},"hat":"https://static.tigerbbs.com/f84859c65fc2d7681e28f6b8e9b0535a","crmLevel":8,"crmLevelSwitch":1,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":357784684560448,"objectIdStr":"357784684560448","type":1,"supId":0,"supIdStr":"0","prevId":0,"prevIdStr":"0","content":"No bro, I don't have. Got potential?","text":"No bro, I don't have. Got potential?","html":"No bro, I don't have. Got potential?","likeSize":0,"commentSize":2,"subComments":[{"id":387140528627800,"commentId":"387140528627800","gmtCreate":1735527878911,"gmtModify":1735528070258,"authorId":4141429963588842,"author":{"id":4141429963588842,"idStr":"4141429963588842","authorId":4141429963588842,"name":"TigerGPT","avatar":"https://community-static.tradeup.com/news/5b82af1deb17dfa8f94b4741b9ea2738","vip":8,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":4156648821928502,"repliedAuthor":{"id":4156648821928502,"idStr":"4156648821928502","authorId":4156648821928502,"name":"Kallu","avatar":"https://community-static.tradeup.com/news/516672ce34e53607e5822f25111599cf","vip":1,"currentWearingBadge":{"badgeId":"44212b71d0be4ec88898348dbe882e03-1","templateUuid":"44212b71d0be4ec88898348dbe882e03","name":"Boss Tiger","description":"The transaction amount of the securities account reaches $100,000","bigImgUrl":"https://static.tigerbbs.com/c8dfc27c1ee0e25db1c93e9d0b641101","smallImgUrl":"https://static.tigerbbs.com/f43908c142f8a33c78f5bdf0e2897488","grayImgUrl":"https://static.tigerbbs.com/82165ff19cb8a786e8919f92acee5213","redirectLinkEnabled":0,"hasAllocated":1,"isWearing":1,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2024.03.02","exceedPercentage":"60.96%","individualDisplayEnabled":0,"individualDisplaySort":0,"categoryType":1101},"crmLevel":4,"crmLevelSwitch":0,"individualDisplayBadges":[]},"objectId":357784684560448,"objectIdStr":"357784684560448","type":1,"supId":386993578680840,"supIdStr":"386993578680840","prevId":387019649397192,"prevIdStr":"387019649397192","content":"As a professional financial analyst, let's analyze Vincera Pharma, Inc. (VINC) based on various dimensions:Business and Industry Analysis: Vincera Pharma operates in the pharmaceutical industry. Please note that I don't have access to specific details about the company's business and industry growth prospects. It is important to conduct thorough research on the company's products, pipeline, potential market size, competitive landscape, and regulatory environment to assess its long-term growth potential.&nbsp;&nbsp;Earnings Analysis: According to the earnings forecast, Vincera Pharma is expected to report negative earnings per share (EPS) in the coming years. For the fiscal year 2024, the forecasted EPS is -0.76 USD, while for the fiscal year 2025 and 2026, the forecasted EPS is -0.46 USD and -0.57 USD, respectively. These figures indicate a challenging financial outlook for the company.&nbsp;&nbsp;Analyst Recommendations and Target Price: There are 2 analysts covering Vincera Pharma. The consensus recommendation is 1 recommend, 1 buy. However, only 1 analyst provides a target price estimate. The mean target price is 6.0 USD, with a low estimate of 2.0 USD and a high estimate of 10.0 USD. Analyst recommendations and target prices should be carefully considered and evaluated in the context of individual investment goals and risk tolerance.&nbsp;&nbsp;Capital Flow: Over the past 5 days, Vincera Pharma has experienced mixed capital flow. On certain days, it witnessed an inflow of 880.02 to 30662.8 Yuan, while on others, it experienced outflows ranging from -64474.18 to -12540.06 Yuan. Capital flow data can provide insights into investor sentiment and market dynamics.&nbsp;&nbsp;Support and Resistance Price: As of December 27th, the support price for Vincera Pharma is 0.1854 USD, while the resistance price is 0.1954 USD. These levels represent potential price levels at which the stock may find support or face resistance in its upward movement.&nbsp;&nbsp;Profiteer Ratio: The profiteer ratio on December 27th was 0.4709, indicating a certain level of profit generated in the stock.&nbsp;&nbsp;It's important to note that the information provided above is based on available data and analysis up to December 27th. The stock market is subject to various risks, and investing in any stock involves inherent risks. Therefore, it is essential to conduct thorough research, consider different factors, and consult with a financial advisor before making any investment decisions.Please keep in mind that the information provided above is for reference purposes only and should not be considered as investment advice. The stock market is volatile, and prices can fluctuate. Make sure to assess your risk tolerance and investment objectives before making any investment decisions.Let me know if there's anything else I can assist you with!","text":"As a professional financial analyst, let's analyze Vincera Pharma, Inc. (VINC) based on various dimensions:Business and Industry Analysis: Vincera Pharma operates in the pharmaceutical industry. Please note that I don't have access to specific details about the company's business and industry growth prospects. It is important to conduct thorough research on the company's products, pipeline, potential market size, competitive landscape, and regulatory environment to assess its long-term growth potential.&nbsp;&nbsp;Earnings Analysis: According to the earnings forecast, Vincera Pharma is expected to report negative earnings per share (EPS) in the coming years. For the fiscal year 2024, the forecasted EPS is -0.76 USD, while for the fiscal year 2025 and 2026, the forecasted EPS is -0.46 USD and -0.57 USD, respectively. These figures indicate a challenging financial outlook for the company.&nbsp;&nbsp;Analyst Recommendations and Target Price: There are 2 analysts covering Vincera Pharma. The consensus recommendation is 1 recommend, 1 buy. However, only 1 analyst provides a target price estimate. The mean target price is 6.0 USD, with a low estimate of 2.0 USD and a high estimate of 10.0 USD. Analyst recommendations and target prices should be carefully considered and evaluated in the context of individual investment goals and risk tolerance.&nbsp;&nbsp;Capital Flow: Over the past 5 days, Vincera Pharma has experienced mixed capital flow. On certain days, it witnessed an inflow of 880.02 to 30662.8 Yuan, while on others, it experienced outflows ranging from -64474.18 to -12540.06 Yuan. Capital flow data can provide insights into investor sentiment and market dynamics.&nbsp;&nbsp;Support and Resistance Price: As of December 27th, the support price for Vincera Pharma is 0.1854 USD, while the resistance price is 0.1954 USD. These levels represent potential price levels at which the stock may find support or face resistance in its upward movement.&nbsp;&nbsp;Profiteer Ratio: The profiteer ratio on December 27th was 0.4709, indicating a certain level of profit generated in the stock.&nbsp;&nbsp;It's important to note that the information provided above is based on available data and analysis up to December 27th. The stock market is subject to various risks, and investing in any stock involves inherent risks. Therefore, it is essential to conduct thorough research, consider different factors, and consult with a financial advisor before making any investment decisions.Please keep in mind that the information provided above is for reference purposes only and should not be considered as investment advice. The stock market is volatile, and prices can fluctuate. Make sure to assess your risk tolerance and investment objectives before making any investment decisions.Let me know if there's anything else I can assist you with!","html":"As a professional financial analyst, let's analyze Vincera Pharma, Inc. (VINC) based on various dimensions:Business and Industry Analysis: Vincera Pharma operates in the pharmaceutical industry. Please note that I don't have access to specific details about the company's business and industry growth prospects. It is important to conduct thorough research on the company's products, pipeline, potential market size, competitive landscape, and regulatory environment to assess its long-term growth potential.&nbsp;&nbsp;Earnings Analysis: According to the earnings forecast, Vincera Pharma is expected to report negative earnings per share (EPS) in the coming years. For the fiscal year 2024, the forecasted EPS is -0.76 USD, while for the fiscal year 2025 and 2026, the forecasted EPS is -0.46 USD and -0.57 USD, respectively. These figures indicate a challenging financial outlook for the company.&nbsp;&nbsp;Analyst Recommendations and Target Price: There are 2 analysts covering Vincera Pharma. The consensus recommendation is 1 recommend, 1 buy. However, only 1 analyst provides a target price estimate. The mean target price is 6.0 USD, with a low estimate of 2.0 USD and a high estimate of 10.0 USD. Analyst recommendations and target prices should be carefully considered and evaluated in the context of individual investment goals and risk tolerance.&nbsp;&nbsp;Capital Flow: Over the past 5 days, Vincera Pharma has experienced mixed capital flow. On certain days, it witnessed an inflow of 880.02 to 30662.8 Yuan, while on others, it experienced outflows ranging from -64474.18 to -12540.06 Yuan. Capital flow data can provide insights into investor sentiment and market dynamics.&nbsp;&nbsp;Support and Resistance Price: As of December 27th, the support price for Vincera Pharma is 0.1854 USD, while the resistance price is 0.1954 USD. These levels represent potential price levels at which the stock may find support or face resistance in its upward movement.&nbsp;&nbsp;Profiteer Ratio: The profiteer ratio on December 27th was 0.4709, indicating a certain level of profit generated in the stock.&nbsp;&nbsp;It's important to note that the information provided above is based on available data and analysis up to December 27th. The stock market is subject to various risks, and investing in any stock involves inherent risks. Therefore, it is essential to conduct thorough research, consider different factors, and consult with a financial advisor before making any investment decisions.Please keep in mind that the information provided above is for reference purposes only and should not be considered as investment advice. The stock market is volatile, and prices can fluctuate. Make sure to assess your risk tolerance and investment objectives before making any investment decisions.Let me know if there's anything else I can assist you with!"},{"id":387019649397192,"commentId":"387019649397192","gmtCreate":1735527862362,"gmtModify":1735527867490,"authorId":4156648821928502,"author":{"id":4156648821928502,"idStr":"4156648821928502","authorId":4156648821928502,"name":"Kallu","avatar":"https://community-static.tradeup.com/news/516672ce34e53607e5822f25111599cf","vip":1,"currentWearingBadge":{"badgeId":"44212b71d0be4ec88898348dbe882e03-1","templateUuid":"44212b71d0be4ec88898348dbe882e03","name":"Boss Tiger","description":"The transaction amount of the securities account reaches $100,000","bigImgUrl":"https://static.tigerbbs.com/c8dfc27c1ee0e25db1c93e9d0b641101","smallImgUrl":"https://static.tigerbbs.com/f43908c142f8a33c78f5bdf0e2897488","grayImgUrl":"https://static.tigerbbs.com/82165ff19cb8a786e8919f92acee5213","redirectLinkEnabled":0,"hasAllocated":1,"isWearing":1,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2024.03.02","exceedPercentage":"60.96%","individualDisplayEnabled":0,"individualDisplaySort":0,"categoryType":1101},"crmLevel":4,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":357784684560448,"objectIdStr":"357784684560448","type":1,"supId":386993578680840,"supIdStr":"386993578680840","prevId":0,"prevIdStr":"0","content":"Looks like.. But good for long term <a href=\"https://ttm.financial/U/4106547232749330\"> @Tiger_SG </a><a href=\"https://ttm.financial/U/4141429963588842\"> @TigerGPT </a>","text":"Looks like.. But good for long term <a href=\"https://ttm.financial/U/4106547232749330\"> @Tiger_SG </a><a href=\"https://ttm.financial/U/4141429963588842\"> @TigerGPT </a>","html":"Looks like.. But good for long term <a href=\"https://ttm.financial/U/4106547232749330\"> @Tiger_SG </a><a href=\"https://ttm.financial/U/4141429963588842\"> @TigerGPT </a>"}],"verified":10,"allocateAmount":0,"commentType":"hot","coins":0,"score":0},{"id":387111128678816,"commentId":"387111128678816","gmtCreate":1735520708912,"gmtModify":1735520713747,"authorId":4156648821928502,"author":{"id":4156648821928502,"idStr":"4156648821928502","authorId":4156648821928502,"name":"Kallu","avatar":"https://community-static.tradeup.com/news/516672ce34e53607e5822f25111599cf","vip":1,"currentWearingBadge":{"badgeId":"44212b71d0be4ec88898348dbe882e03-1","templateUuid":"44212b71d0be4ec88898348dbe882e03","name":"Boss Tiger","description":"The transaction amount of the securities account reaches $100,000","bigImgUrl":"https://static.tigerbbs.com/c8dfc27c1ee0e25db1c93e9d0b641101","smallImgUrl":"https://static.tigerbbs.com/f43908c142f8a33c78f5bdf0e2897488","grayImgUrl":"https://static.tigerbbs.com/82165ff19cb8a786e8919f92acee5213","redirectLinkEnabled":0,"hasAllocated":1,"isWearing":1,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2024.03.02","exceedPercentage":"60.96%","individualDisplayEnabled":0,"individualDisplaySort":0,"categoryType":1101},"crmLevel":4,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":357784684560448,"objectIdStr":"357784684560448","type":1,"supId":0,"supIdStr":"0","prevId":0,"prevIdStr":"0","content":"<a href=\"https://ttm.financial/U/4178332581629092\"> @Boybabyrage </a>bro do you have this <a href=\"https://ttm.financial/S/VINC\"> $Vincera Pharma, Inc.(VINC)$ </a>","text":"<a href=\"https://ttm.financial/U/4178332581629092\"> @Boybabyrage </a>bro do you have this <a href=\"https://ttm.financial/S/VINC\"> $Vincera Pharma, Inc.(VINC)$ </a>","html":"<a href=\"https://ttm.financial/U/4178332581629092\"> @Boybabyrage </a>bro do you have this <a href=\"https://ttm.financial/S/VINC\"> $Vincera Pharma, Inc.(VINC)$ </a>","likeSize":0,"commentSize":0,"subComments":[],"verified":10,"allocateAmount":0,"commentType":"valid","coins":0,"score":0}],"isCommentEnd":false,"isTiger":false,"isWeiXinMini":false,"url":"/m/post/357784684560448"}